Thomas Shrader
Stock Analyst at BTIG
(2.40)
# 2,067
Out of 4,479 analysts
36
Total ratings
42.31%
Success rate
1.73%
Average return
Main Sectors:
Top Industries:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OVID Ovid Therapeutics | Maintains: Buy | $11 → $5 | $0.77 | +546.50% | 2 | Jun 18, 2024 | |
| ACIU AC Immune | Initiates: Buy | $8 | $3.87 | +106.72% | 1 | May 31, 2024 | |
| PMN ProMIS Neurosciences | Initiates: Buy | $8 | $1.66 | +381.93% | 1 | Oct 3, 2023 | |
| DTIL Precision BioSciences | Maintains: Buy | $180 → $60 | $9.41 | +537.62% | 1 | Jul 28, 2023 | |
| BHVN Biohaven Pharmaceutical Holding Company | Reiterates: Buy | $24 | $34.17 | -29.76% | 2 | Jun 6, 2023 | |
| ANNX Annexon | Maintains: Buy | $15 → $7 | $4.57 | +53.34% | 2 | May 25, 2023 | |
| COYA Coya Therapeutics | Initiates: Buy | $15 | $6.05 | +147.93% | 1 | May 18, 2023 | |
| ATHA Athira Pharma | Maintains: Buy | $33 → $10 | $2.52 | +296.83% | 2 | Mar 30, 2023 | |
| BCAB BioAtla | Maintains: Buy | $68 → $13 | $1.32 | +884.85% | 3 | Mar 28, 2023 | |
| VRNA Verona Pharma | Maintains: Buy | $26 → $31 | $15.46 | +100.52% | 3 | Mar 20, 2023 | |
| ALEC Alector | Maintains: Buy | $54 → $16 | $4.34 | +268.66% | 1 | Mar 2, 2023 | |
| PCVX Vaxcyte | Initiates: Buy | $69 | $76.06 | -9.28% | 1 | Nov 17, 2022 | |
| GANX Gain Therapeutics | Maintains: Buy | $30 → $10 | $1.20 | +736.82% | 2 | Nov 14, 2022 | |
| ABOS Acumen Pharmaceuticals | Maintains: Buy | $15 → $22 | $2.27 | +869.16% | 2 | Oct 5, 2022 | |
| INMB INmune Bio | Maintains: Buy | $31 → $14 | $8.07 | +73.48% | 2 | May 24, 2022 | |
| NUVB Nuvation Bio | Initiates: Buy | n/a | $2.98 | - | 1 | Mar 8, 2021 | |
| VYGR Voyager Therapeutics | Downgrades: Neutral | n/a | $7.59 | - | 1 | Feb 3, 2021 | |
| DNLI Denali Therapeutics | Downgrades: Neutral | n/a | $21.74 | - | 1 | Oct 16, 2020 | |
| VCNX Vaccinex | Downgrades: Neutral | n/a | $6.68 | - | 1 | Sep 23, 2020 | |
| ETNB 89bio | Maintains: Buy | n/a | $7.60 | - | 1 | Sep 15, 2020 | |
| GERN Geron | Maintains: Buy | n/a | $4.17 | - | 1 | Apr 3, 2020 | |
| BIIB Biogen | Downgrades: Hold | n/a | $228.82 | - | 3 | Feb 21, 2019 | |
| WINT Windtree Therapeutics | Downgrades: Hold | n/a | $3.13 | - | 1 | Jun 30, 2017 |
Ovid Therapeutics
Jun 18, 2024
Maintains: Buy
Price Target: $11 → $5
Current: $0.77
Upside: +546.50%
AC Immune
May 31, 2024
Initiates: Buy
Price Target: $8
Current: $3.87
Upside: +106.72%
ProMIS Neurosciences
Oct 3, 2023
Initiates: Buy
Price Target: $8
Current: $1.66
Upside: +381.93%
Precision BioSciences
Jul 28, 2023
Maintains: Buy
Price Target: $180 → $60
Current: $9.41
Upside: +537.62%
Biohaven Pharmaceutical Holding Company
Jun 6, 2023
Reiterates: Buy
Price Target: $24
Current: $34.17
Upside: -29.76%
Annexon
May 25, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $4.57
Upside: +53.34%
Coya Therapeutics
May 18, 2023
Initiates: Buy
Price Target: $15
Current: $6.05
Upside: +147.93%
Athira Pharma
Mar 30, 2023
Maintains: Buy
Price Target: $33 → $10
Current: $2.52
Upside: +296.83%
BioAtla
Mar 28, 2023
Maintains: Buy
Price Target: $68 → $13
Current: $1.32
Upside: +884.85%
Verona Pharma
Mar 20, 2023
Maintains: Buy
Price Target: $26 → $31
Current: $15.46
Upside: +100.52%
Alector
Mar 2, 2023
Maintains: Buy
Price Target: $54 → $16
Current: $4.34
Upside: +268.66%
Vaxcyte
Nov 17, 2022
Initiates: Buy
Price Target: $69
Current: $76.06
Upside: -9.28%
Gain Therapeutics
Nov 14, 2022
Maintains: Buy
Price Target: $30 → $10
Current: $1.20
Upside: +736.82%
Acumen Pharmaceuticals
Oct 5, 2022
Maintains: Buy
Price Target: $15 → $22
Current: $2.27
Upside: +869.16%
INmune Bio
May 24, 2022
Maintains: Buy
Price Target: $31 → $14
Current: $8.07
Upside: +73.48%
Nuvation Bio
Mar 8, 2021
Initiates: Buy
Price Target: n/a
Current: $2.98
Upside: -
Voyager Therapeutics
Feb 3, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.59
Upside: -
Denali Therapeutics
Oct 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $21.74
Upside: -
Vaccinex
Sep 23, 2020
Downgrades: Neutral
Price Target: n/a
Current: $6.68
Upside: -
89bio
Sep 15, 2020
Maintains: Buy
Price Target: n/a
Current: $7.60
Upside: -
Geron
Apr 3, 2020
Maintains: Buy
Price Target: n/a
Current: $4.17
Upside: -
Biogen
Feb 21, 2019
Downgrades: Hold
Price Target: n/a
Current: $228.82
Upside: -
Windtree Therapeutics
Jun 30, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.13
Upside: -